Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01749358 · ClinicalTrials.gov registry record · Phase 1
Dose Optimization for Stroke Evaluation
A Phase 1 study of Stroke and Cerebrovascular Disorders, sponsored by University of Southern California.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT01749358 is a Phase 1 study of Stroke and Cerebrovascular Disorders that has completed, run by University of Southern California. The registered enrollment target is 60 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01749358, a Phase 1 study of Stroke and Cerebrovascular Disorders, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is about rehabilitation of arm function after a stroke. The investigators are testing the dosage of therapy that is needed for meaningful recovery of arm and hand function. Dosage of therapy refers to the amount of time (in this case, the total number of hours) that a person participates in treatment. The investigators hope to learn how much therapy time is needed in order for change to occur in arm and hand function after a person has had a stroke. Eligible candidates must have had a stroke affecting the use of an arm or hand at least 6 months ago.
Conditions Studied
Interventions
- BEHAVIORAL Accelerated Skill Acquisition Program (ASAP)
- BEHAVIORAL Active Monitoring
Study Locations (1)
California
- University of Southern California-Health Sciences Campus - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-03 |
| Est. Completion | 2016-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01749358
The ClinicalTrials.gov registry entry for NCT01749358 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Accelerated Skill Acquisition Program (ASAP) is the first listed.
NCT01749358 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01749358 about?
NCT01749358 is a clinical study titled "Dose Optimization for Stroke Evaluation". This study is about rehabilitation of arm function after a stroke. The investigators are testing the dosage of therapy that is needed for meaningful recovery of arm and hand function. Dosage of therapy refers to the amount of time (in this case, the total number of hours) that a person participates ...
What is the current status of trial NCT01749358?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2012-03. Estimated completion is 2016-08.
What conditions does trial NCT01749358 study?
This clinical trial studies the following conditions: Stroke, Cerebrovascular Disorders, Brain Ischemia, Infarction.
What interventions are being tested in trial NCT01749358?
The interventions under investigation include: Accelerated Skill Acquisition Program (ASAP) (BEHAVIORAL), Active Monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT01749358?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01749358 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
RECRUITING · Phase 1
-
Hybrid Robot+FES Stroke Rehabilitation
RECRUITING · Phase 1
-
Vibrotactile Stimulation for Upper-Extremity Stroke Rehabilitation
RECRUITING · Phase 1
-
Facilitating Neuroplastic Changes of Acute Stroke Survivors
RECRUITING · Phase 1
-
Identifying Personalized Brain States Predicting Residual Corticospinal Tract Output After Stroke
RECRUITING · Phase 1
-
Accelerated rTMS vs. Sham for Stroke Apathy
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.